Skip to main content
. 2022 Mar 2;13:859516. doi: 10.3389/fphar.2022.859516

FIGURE 1.

FIGURE 1

Mesenchymal stem cells’ (MSCs) mechanisms of action as potential therapeutic strategies for lysosomal storage diseases and other neurodegenerative diseases; (1) Homing and engraftment in sites of injured cells, (2) differentiation into neural precursor cells, glial cells and astrocytes, (3) secretion of growth factors and neuromodulators to help cross correct damaged cells, (4) in vivo cross correction by releasing deficient lysosomal enzymes.